We are live on ! Find out more
ACM

Alethea Capital Management Portfolio holdings

AUM $195M
1-Year Est. Return 51.17%
This Fund
S&P 500
This Quarter Est. Return
-8.3%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$79.9M
AUM Growth
-$30.7M
Cap. Flow
-$18.9M
Cap. Flow %
-23.6%
Top 10 Hldgs %
76.99%
Holding
80
New
15
Increased
5
Reduced
30
Closed
16

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$548K
2
WBA
Walgreens Boots Alliance
WBA
+$528K
3
PM icon
Philip Morris
PM
+$513K
4
GLW icon
Corning
GLW
+$510K
5
HAS icon
Hasbro
HAS
+$500K

Sector Composition

Rank Sector Weight
1 Healthcare 66.61%
2 Financials 4.31%
3 Consumer Staples 4.09%
4 Technology 3.61%
5 Industrials 3.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
76
RTX Corp
RTX
$301B
-9,430
Closed -$934K
SLG icon
77
SL Green Realty
SLG
$3.99B
-3,496
Closed -$284K
TXN icon
78
Texas Instruments
TXN
$261B
-3,849
Closed -$706K
WMB icon
79
Williams Companies
WMB
$86.1B
-27,672
Closed -$925K
ZION icon
80
Zions Bancorporation
ZION
$10.3B
-11,333
Closed -$743K

Similar funds

Alethea Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Alethea Capital Management held 80 positions worth $79.9M, down 28% from $111M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Alethea Capital Management withdrew a net $18.9M in Q2 2022, closing 16 positions and reducing 30 holdings. Its most notable exit was Coterra Energy, an estimated $1.02M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Alethea Capital Management opened a new position in Gilead Sciences worth $547K.

  • Alethea Capital Management's largest Q2 2022 buy was Gilead Sciences: 8,850 shares worth $547K.
  • Alethea Capital Management added most to Kimberly-Clark in Q2 2022, an estimated $440K increase.
  • Alethea Capital Management's biggest Q2 2022 reduction was Axsome Therapeutics, cutting an estimated $8.01M.
  • Alethea Capital Management fully exited Coterra Energy in Q2 2022, selling an estimated $1.02M.
  • Alethea Capital Management's ten largest holdings make up 77% of its $79.9M portfolio in Q2 2022.
  • Alethea Capital Management opened 15 new positions and closed 16 in Q2 2022.
  • Alethea Capital Management's portfolio value fell 28% quarter-over-quarter to $79.9M.

Based on Alethea Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.